PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME
申请人:Mikoshiba Katsuhiko
公开号:US20120277423A1
公开(公告)日:2012-11-01
The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3:
wherein R
1
is a substituted or unsubstituted aryl or heterocyclyl group, R
2
, R
3
, and R
4
are hydrogen atoms, n is 2, X is halogen, R
5
and R
6
independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R
5
and R
6
are not hydrogen atoms at the same time, or R
5
and R
6
may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.